Roth Capital Downgrades Aeolus Pharmaceuticals (AOLS) to Neutral
Tweet
Share
E-mailGet Alerts AOLS Hot Sheet
Price: $0.00 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Join SI Premium – FREE
Roth Capital downgraded Aeolus Pharmaceuticals (OTCBB: AOLS) from Buy to Neutral with a price target of $1.00 (from $3.00).
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday.
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- JPMorgan Downgrades Bowman Consulting Group Ltd. (BWMN) to Underweight
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
